Company logo

ONCT - Oncternal Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

ONCT price evolution
ONCT
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $6.38 $6.4 $6.7
Short term investments $15.05 $20.63 $27.56
Net receivables $0.34 $0.56 $0.72
Inventory
Total current assets $15.45 $23.26 $28.5 $36.06
Long term investments
Property, plant & equipment $0.15 $0.19 $0.23 $0.26
Goodwill & intangible assets
Total noncurrent assets $0.6 $0.64 $0.67
Total investments $15.05 $20.63 $27.56
Total assets $15.6 $23.86 $29.14 $36.73
Current liabilities
Accounts payable $1.2 $1.9 $1.46 $1.15
Deferred revenue
Short long term debt $0.18 $0.18 $0.17
Total current liabilities $6.45 $8.05 $6.12 $5.2
Long term debt $0.05 $0.1 $0.14
Total noncurrent liabilities $0.05 $0.1 $1.48
Total debt $0.23 $0.28 $0.32
Total liabilities $6.45 $8.11 $6.21 $6.68
Shareholders' equity
Retained earnings -$223.19 -$214.73 -$206.17 -$197.78
Other shareholder equity $0 -$0 -$0.01 $0
Total shareholder equity $15.75 $22.93 $30.05
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $6.7 $37.14 $90.77 $116.74
Short term investments $27.56 $26.58
Net receivables $0.63 $0.18
Inventory
Total current assets $36.06 $67.29 $92.85 $118
Long term investments
Property, plant & equipment $0.26 $0.09 $0.07 $0.04
Goodwill & intangible assets
Total noncurrent assets $0.67 $1.36 $0.73 $0.81
Total investments $27.56 $26.58
Total assets $36.73 $68.65 $93.58 $118.81
Current liabilities
Accounts payable $1.15 $2.92 $1.96 $1.14
Deferred revenue $1.63
Short long term debt $0.17 $0.09 $0.07 $0.04
Total current liabilities $5.2 $7.68 $5.46 $5.86
Long term debt $0.14
Total noncurrent liabilities $1.48
Total debt $0.32 $0.09 $0.07 $0.04
Total liabilities $6.68 $7.68 $5.46 $5.86
Shareholders' equity
Retained earnings -$197.78 -$158.3 -$114.13 -$82.8
Other shareholder equity $0 $0.01
Total shareholder equity $30.05 $60.97 $88.12 $112.95
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $0.8 $0.57 $0.3
Cost of revenue
Gross Profit $0.8 $0.57 $0.3
Operating activities
Research & development $6.61 $6.06 $6.67
Selling, general & administrative $3.05 $3.29 $3.26
Total operating expenses $9.66 $9.35 $9.93
Operating income -$8.86 -$8.78 -$9.64
Income from continuing operations
EBIT -$8.56 -$8.39 -$9.16
Income tax expense
Interest expense
Net income
Net income -$8.56 -$8.39 -$9.16
Income (for common shares) -$8.56 -$8.39 -$9.16
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $0.79 $1.49 $4.32 $3.38
Cost of revenue
Gross Profit $0.79 $1.49 $4.32 $3.38
Operating activities
Research & development $29.75 $32.98 $24.09 $12.54
Selling, general & administrative $12.75 $13.46 $11.6 $8.37
Total operating expenses $42.5 $46.44 $35.68 $20.92
Operating income -$41.71 -$44.95 -$31.37 -$17.54
Income from continuing operations
EBIT -$39.48 -$44.17 -$31.33 -$17.23
Income tax expense
Interest expense
Net income
Net income -$39.48 -$44.17 -$31.33 -$17.23
Income (for common shares) -$39.48 -$44.17 -$31.33 -$17.23
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income -$8.56 -$8.39 -$9.16
Operating activities
Depreciation $0.04 $0.03 $0.03
Business acquisitions & disposals
Stock-based compensation $1.38 $1.36 $2.22
Total cash flows from operations -$5.82 -$7.44 -$6.42
Investing activities
Capital expenditures
Investments $5.81 $7.22 -$1.81
Total cash flows from investing $26.68 $5.81 $7.22 -$1.81
Financing activities
Dividends paid
Sale and purchase of stock -$0.09 -$0
Net borrowings
Total cash flows from financing -$0.09 -$0.09 -$0
Effect of exchange rate
Change in cash and equivalents $6.38 -$0.01 -$0.3 -$8.23
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$39.48 -$44.17 -$31.33 -$17.23
Operating activities
Depreciation $0.17 $0.18 $0.17 $0.15
Business acquisitions & disposals
Stock-based compensation $7.5 $7.43 $5.88 $1.56
Total cash flows from operations -$32.16 -$36.7 -$26.59 -$17.5
Investing activities
Capital expenditures
Investments $0.65 -$26.5
Total cash flows from investing $0.65 -$26.5
Financing activities
Dividends paid
Sale and purchase of stock $1.07 $9.58 $0.62 $113.88
Net borrowings $0.3
Total cash flows from financing $1.07 $9.58 $0.62 $114.18
Effect of exchange rate
Change in cash and equivalents -$30.45 -$53.62 -$25.97 $96.69
Fundamentals
Market cap $1.57M
Enterprise value N/A
Shares outstanding 2.96M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.22
Net debt/EBITDA N/A
Current ratio 2.39
Quick ratio N/A